Axcelead Drug Discovery Partners and Acadia Pharmaceuticals Launch 2nd Drug Discovery Project in Neuroscience
December 25, 2023 – Axcelead Drug Discovery Partners, Inc. …
How to proceed GLP toxicity study without cynomolgus monkeys
High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery.
Rapid Discovery! Accelerate drug discovery from hit id to clinic
Mounting competitive pressure is forcing the biopharma industry to look at new ways to shorten the time scale for all aspects of drug discovery.
Driving innovative drug discovery through integrated high-throughput screening platform
High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug discovery. The innovative technologies for drugging undruggable targets and IPS cells have been shed new light on small molecule drug discovery.
In-Vivo Science and Axcelead DDP Entered into Cooperative Agreement for Drug Discovery Services Using Disease Model Animals
In-Vivo Science, Inc. (Headquarters: Meguro-ku, Tokyo; Branch Office: …
